Acne-like rash predicts response in patients treated with Cetuximab (IMC-C225) plus Irinotecan (CPT-11) in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR) Meeting Abstract


Authors: Saltz, L.; Rubin, M. S.; Hochster, H. S.; Tchekmeydian, N. S.; Waksal, H. W.; Needle, M. N.; Lobuglio, A. F.
Abstract Title: Acne-like rash predicts response in patients treated with Cetuximab (IMC-C225) plus Irinotecan (CPT-11) in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR)
Meeting Title: 2001 AACR-NCI-EORTC International Conference - Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
Journal Title: Clinical Cancer Research
Volume: 7
Issue: 11 Suppl.
Meeting Dates: 2001 Oct 29-Nov 2
Meeting Location: Miami Beach, FL
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2001-11-01
Start Page: 3766s
Language: English
ACCESSION: WOS:000172121800551
PROVIDER: wos
PUBMED: 11727717
Notes: Meeting Abstract: 559 -- Source: Wos
Citation Impact
MSK Authors
  1. Leonard B Saltz
    790 Saltz